FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades

October 11, 2019

Eli Lilly won FDA approval for a migraine drug on Friday, giving the pharmaceutical giant a second medication that addresses the condition that causes millions of people to experience severe headaches and other debilitating symptoms.
More »

Veracyte to Announce New Clinical Data for First Noninvasive Nasal Swab Test to Target Early Lung Cancer Detection at CHEST Annual Meeting 2019

October 7, 2019

Five Studies Reinforcing Clinical Performance and Utility of Company’s Marketed Genomic Tests in Lung Cancer and IPF Diagnosis Will Also Be Presented
More »

Milestone Pharmaceuticals Announces First Patient Enrolled in NODE-303 Open-label Safety Study of Etripamil in PSVT

October 3, 2019

Milestone Pharmaceuticals Inc. (Nasdaq: MIST), today announced that the first patient has been enrolled in the Phase 3 NODE-303 study.
More »